4598 — Delta-Fly Pharma Share News
0.000.00%
Table: Delta-Fly Pharma -2025/26 parent results
Table: Delta-Fly Pharma - 9-MTH parent results
Table: Delta-Fly Pharma - 6-MTH parent results
Table: Delta-Fly Pharma - Q1 parent results
Table: Delta-Fly Pharma -2024/25 parent results
Table: Delta-Fly Pharma - 9-MTH parent results
Table: Delta-Fly Pharma - 6-MTH parent results
Brief: Delta-Fly Pharma Inc Update For Expanded Phase I Study Of DFP-14927
Brief: Delta-Fly Pharma Inc. Phase I/Ii Study Of Dfp-10917 And Venetoclax In Aml Patients Begins With Promising Initial Data
Table: Delta-Fly Pharma - Q1 parent results
Table: Delta-Fly Pharma -2023/24 parent results
Table: Delta-Fly Pharma - 9-MTH parent results
Table: Delta-Fly Pharma - 6-MTH parent results
Table: Delta-Fly Pharma - Q1 parent results
Table: Delta-Fly Pharma -2022/23 parent results
Table: Delta-Fly Pharma -2022/23 parent forecast
Table: Delta-Fly Pharma - 9-MTH parent results
Table: Delta-Fly Pharma - 6-MTH parent results
Table: Delta-Fly Pharma - Q1 parent results